ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Cheng‐Wei Chou
Matched on ORCID iD 0000-0003-1801-4964; OpenAlex author ID A5003757557, A5091123976. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. Co-author DOI 10.1038/s41467-026-72271-5↗
- The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary ce… Last author DOI 10.1177/17588359241247019↗
- Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines9111601↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hsin‐Chen Lin · 1 shared paper, 2024 · strength 0.24
- Kuan-Yu Tseng · 1 shared paper, 2024 · strength 0.24
- Ching-Fei Li · 1 shared paper, 2026 · strength 0.21
- Yongkun Wei · 1 shared paper, 2026 · strength 0.21
- Jianhua Ling · 1 shared paper, 2026 · strength 0.21
- Huamin Wang · 1 shared paper, 2026 · strength 0.21
- Ying‐Nai Wang · 1 shared paper, 2026 · strength 0.21
- Jie Fu · 1 shared paper, 2026 · strength 0.21
- Haoqiang Ying · 1 shared paper, 2026 · strength 0.21
- Paul J. Chiao · 1 shared paper, 2026 · strength 0.21
- Li‐Yuan Bai · 1 shared paper, 2026 · strength 0.21
- Dihua Yu · 1 shared paper, 2026 · strength 0.21
- Wantong Yao · 1 shared paper, 2026 · strength 0.21
- Anirban Maitra · 1 shared paper, 2026 · strength 0.21
- Mien‐Chie Hung · 1 shared paper, 2026 · strength 0.21
- Wan‐Jou Shen · 1 shared paper, 2021 · strength 0.12
- Wei‐Jan Wang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.